Selecting short length nucleic acids localized in exosomes improves plasma EGFR mutation detection in NSCLC patients
Abstract Background Exosomal nucleic acid (exoNA) is a feasible target to improve the sensitivity of EGFR mutation testing in non-small cell lung cancer patients with limited cell-free DNA (cfDNA) mutant copies. However, the type and size of target exoNA related to the sensitivity of EGFR mutation t...
Main Authors: | Yoonjung Kim, Saeam Shin, Boyeon Kim, Kyung-A Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-019-0978-8 |
Similar Items
-
Detection of circulating KRAS mutant DNA in extracellular vesicles using droplet digital PCR in patients with colon cancer
by: Jeesoo Choi, et al.
Published: (2022-12-01) -
Small EVs-Associated DNA as Complementary Biomarker to Circulating Tumor DNA in Plasma of Metastatic Colorectal Cancer Patients
by: Silvia Galbiati, et al.
Published: (2021-02-01) -
Exosome-based detection of EGFR T790M in plasma and pleural fluid of prospectively enrolled non-small cell lung cancer patients after first-line tyrosine kinase inhibitor therapy
by: Yoonjung Kim, et al.
Published: (2021-01-01) -
Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
by: Giuseppe Gattuso, et al.
Published: (2022-08-01) -
Detection of clinically-relevant <em>EGFR</em> variations in <em>de novo</em> small cell lung carcinoma by droplet digital PCR
by: Rajesh Venkataram, et al.
Published: (2022-09-01)